| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,039,000 | 3,722,000 | 3,103,000 | 4,067,000 | | Cost of Revenue | 2,018,000 | 2,113,000 | 2,122,000 | (430,000) | | | Gross Profit | 2,021,000 | 1,609,000 | 981,000 | 4,497,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 464,000 | 472,000 | 375,000 | 572,000 | | Non Recurring | 178,000 |
-
|
-
| 647,000 | | Others |
-
|
-
|
-
| 2,710,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,379,000 | 1,137,000 | 606,000 | 568,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 87,000 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,466,000 | 1,137,000 | 606,000 | 568,000 | | Interest Expense | 40,000 | 32,000 | 27,000 | 35,000 | | Income Before Tax | 1,426,000 | 1,105,000 | 579,000 | 533,000 | | Income Tax Expense | 549,000 | 455,000 | 241,000 | 118,000 | | Minority Interest | (35,000) |
-
|
-
| (12,000) | | | | Net Income From Continuing Ops | 943,000 | 696,000 | 380,000 | 448,000 | | | Non-recurring Events | | Discontinued Operations | (2,000) | (2,000) | (3,000) | (5,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 906,000 | 694,000 | 377,000 | 443,000 | | Preferred Stock And Other Adjustments | 21,000 | (12,000) | (9,000) |
-
| | | Net Income Applicable To Common Shares | $927,000 | $682,000 | $368,000 | $443,000 |
|
0.17% Nasdaq 
0.06 (0.07%) 
Income Statement
